Legal basis: Article 17 (1) of the Regulation (EU) No 596/2014 of the European Parliament and the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC\ The Board of Directors of NESTMEDIC SA, a joint-stock company, with its registered office in Wrocław (the “Company”) announces that on July 3, 2017 the Company and Medicover Sp. z o.o., a limited liability company with its registered office in Warsaw signed a letter of intent.
Signing a letter of intent
Current Report No. 3/2017